Dose scaling and extrapolation across age groups

Human and Ecological Risk Assessment

Volumn 8, Issue 4, 2002, Pages 783-803

  Rhomberg, Lorenz R ^a  

^a GRADIENT   (United States)

Author keywords

Children's risk; Interspecies scaling; Pharmacodynamics; Pharmacokinetics; Uncertainty factors

Indexed keywords

EID: 2342425511     PISSN: 10807039     EISSN: None     Source Type: Journal    
DOI: 10.1080/10807030290879952     Document Type: Article

References (25)

1. Adolph EF. 1949. Quantitative relations in the physiological constitution of mammals. Science 109:579-85
2. Baird SJS, Cohen JT, Graham JD, et al. 1996. Noncancer risk assessment: A probabilistic alternative to current practice. Human Ecol Risk Assess 2(1):79-102
3. Boxenbaum H. 1983. Evolutionary biology, animal behavior, fourth-dimensional space, and the raison d'Ítre of drug metabolism and pharmacokinetics. Drug Metab Rev 14:1057-97
4. Crom WR. 1994. Pharmacokinetics in the child. Environ Health Perspect 102(suppl. 11):111-7
5. Dedrick RL. 1973. Animal scale-up. J Pharma Biopharm 1:435-61
6. Dourson ML and Stara JF. 1983. Regulatory history and experimental support of uncertainty (safety) factors. Regulatory Toxicol Pharmacol 3:224-38
7. Evans JS, Rhomberg LR, Williams PL, et al. 2001. Reproductive and developmental risks from ethylene oxide: a probabilistic characterization of possible regulatory thresholds. Risk Anal 21:697-717
8. Ings RJM. 1990. Interspecies scaling and comparisons in drug development and toxicokinetics. Xenobiotica 20:1202-31
9. Kleiber M. 1932. Body size and metabolism. Hilgardia 6:315-53
10. McMahon TA and Bonner JT. 1983. On Size and Life. Scientific American Books, NY, NY, USA
11. Mordenti J. 1986. Man versus beast: Pharmacokinetic scaling in mammals. J Pharmacol Sci 75:1028-40
12. Munro H N. 1964. Evolution of Protein Metabolism in Mammals. In: Munro HN (ed), Mammalian Protein Metabolism, vol 2, pp 133-82. Academic Press, NY, NY, USA
13. O'Flaherty EL. 1989. Interspecies conversion of kinetically equivalent doses. Risk Anal 9:587-98
14. Peters RH. 1983. The Ecological Implications of Body Size. Cambridge University Press, Cambridge, UK
15. Plunkett LM, Turnbull D, and Rodricks JV. 1992. Differences Between Adults and Children Affecting Exposure Assessment. In: Guzelian PS, Henry CJ, and Olin SS (eds), Similarities and Differences Between Children and Adults: Implications for Risk Assessment, pp 79-94. International Life Sciences Institute (ILSI) Press, Washington, DC, USA
16. Rhomberg LR. 1995. What Constitutes "Dose"? In: Olin S, Farland W, Park C, et al. (eds), Low-Dose Extrapolation of Cancer Risks: Issues and Perspectives, pp 185-98. International Life Sciences Institute (ILSI) Press, Washington, DC, USA
17. Rhomberg LR. 1997. A survey of methods for chemical health risk assessment among federal regulatory agencies. Human Ecol Risk Assess 3(6):1029-196
18. Rhomberg LR and Wolff SK. 1998. Empirical scaling of single oral lethal doses across mammalian species based on a large database. Risk Anal 18(6):741-53
19. Schmidt-Nielsen K. 1984. Scaling: Why is Animal Size So Important? Cambridge University Press, Cambridge, UK
20. Thompson D'AW. 1992. On Growth and Form: The Complete Revised Edition. Dover, NY, NY, USA
21. Travis CC and White RK 1988. Interspecies scaling of toxicity data. Risk Anal 8(1):119-25
22. 3/4/day; notice. Federal Reg 57(109):24152-73
23. USEPA (U.S. Environmental Protection Agency). 1994. Methods for Derivation of Inhalation Reference Concentration Application of Inhalation Dosimetry. EPA/600/8-90/066F. Office of Health and Environmental Assessment, Research Triangle Park, NC, USA
24. USEPA (U.S. Environmental Protection Agency). 1996. Proposed Guidelines for Carcinogen Risk Assessment. EPA/600/P-92/003C. Office of Research and Development, Washington, DC, USA
25. USEPA (U.S. Environmental Protection Agency). 1997. Exposure Factors Handbook, Vol. 1: General Factors. EPA/600/P-95/002Fa. Office of Research and Development, Washington, DC, USA